Haematology of pregnancy and the newborn: anaemia, low platelets, clots and HDFN
- Look-alikes compared
Pregnancy changes the normal blood count and raises the risk of clots. Knowing what is normal stops false alarms and catches the dangerous few.
What it is
In pregnancy plasma volume rises more than red cell mass, so haemoglobin falls by dilution; neutrophils rise; platelets fall slightly; and clotting factors and fibrinogen rise while natural anticoagulants fall, preparing for delivery but raising the risk of venous thrombosis, which peaks after birth. Iron deficiency is the commonest true anaemia. A low platelet count may be harmless gestational thrombocytopenia, immune thrombocytopenia, or part of preeclampsia and HELLP. Maternal antibodies against fetal red cells cause haemolytic disease of the fetus and newborn (HDFN), largely prevented by anti-D immunoglobulin.
The difference in one line
- Anaemia in pregnancy is defined at a lower cut-off than outside pregnancy (WHO: below 110 grams per litre); iron deficiency is the commonest cause, and iron and folic acid are part of routine prenatal care.
- Gestational thrombocytopenia: mild, late in pregnancy, no previous history, resolves after delivery and does not affect the baby.
- ITP can start at any time, often earlier and with lower counts; maternal IgG can cross the placenta and lower the baby's platelets.
- HELLP (haemolysis, elevated liver enzymes, low platelets) belongs to the preeclampsia spectrum; delivery is the definitive treatment.
- Venous thrombosis risk is highest in the weeks after delivery; low molecular weight heparin is the usual anticoagulant because it does not cross the placenta; warfarin and direct oral anticoagulants are avoided.
- HDFN: an RhD-negative mother exposed to RhD-positive fetal cells can make anti-D, which crosses the placenta in a later pregnancy and destroys the baby's red cells; anti-D immunoglobulin prevents sensitisation.
- Newborns have a high haemoglobin with mostly fetal haemoglobin, which falls to a physiological low at around two to three months; vitamin K is given at birth to prevent bleeding.
Low platelets in pregnancy
| Feature | Gestational thrombocytopenia | Immune thrombocytopenia (ITP) | Preeclampsia and HELLP | TTP |
|---|---|---|---|---|
| Timing | Late second and third trimester | Any time; may predate pregnancy | After 20 weeks, often third trimester or postpartum | Any time; rare |
| Platelet count | Mildly low (usually above about 70 × 10⁹/L) | Can be very low | Falling, sometimes fast | Very low |
| Other findings | None; well woman | Bruising or none; normal smear apart from large platelets | Hypertension, proteinuria, raised liver enzymes, haemolysis | Schistocytes, haemolysis, neurological or kidney signs; very low ADAMTS13 |
| Baby | Not affected | Can be born with low platelets | Affected by placental insufficiency and preterm birth | Placental damage |
| Management principle | Observe; confirm it settles after birth | Treat if count is very low or for delivery; plan anaesthesia | Control blood pressure, prevent seizures, deliver | Urgent plasma exchange with haematology |
In clinical practice
- Headache, visual change, upper abdominal pain or a rising blood pressure with falling platelets means preeclampsia or HELLP until proven otherwise.
- Anti-D is given to RhD-negative women at around 28 weeks, after the birth of an RhD-positive baby (within 72 hours) and after sensitising events such as miscarriage, abortion, ectopic pregnancy, abdominal trauma or invasive procedures.
- ABO HDFN (group O mother, group A or B baby) can occur in a first pregnancy and is usually mild: early jaundice treated with phototherapy.
- Postpartum haemorrhage consumes fibrinogen early; in Colombia it is managed through Código Rojo (hmt_massive_transfusion).
How it is confirmed
- First prenatal visit: blood count, group and antibody screen, and haemoglobin analysis where haemoglobin disorders are common; repeat the count and screen later in pregnancy.
- Low platelets: repeat with a smear, blood pressure, urine protein, liver tests, LDH; schistocytes or very low counts need same-day obstetric and haematology review.
- RhD-negative woman after a sensitising event or birth: test for the size of fetomaternal bleeding (Kleihauer–Betke or flow cytometry) to decide the amount of anti-D.
- Antibody found in pregnancy: identify it and follow the titre; fetal anaemia is monitored by middle cerebral artery Doppler and treated by intrauterine transfusion.
Common traps
- Calling a low haemoglobin in pregnancy 'just dilution': check ferritin first.
- Using a D-dimer to exclude thrombosis in late pregnancy: it rises normally in pregnancy.
- Labelling a falling platelet count as gestational: check blood pressure, urine and liver tests first.
- Forgetting anti-D in an RhD-negative woman: it is needed after a miscarriage, ectopic pregnancy or abdominal trauma.
- Giving warfarin in early pregnancy: it crosses the placenta and can cause embryopathy.
Test yourself
Think of the answer, then tap the question to see it.
Why does haemoglobin fall in a normal pregnancy, and why does it not mean the woman is healthy if it falls far?
Plasma volume rises more than red cell mass, diluting the haemoglobin; a fall below the pregnancy cut-off is anaemia, most often iron deficiency, and needs testing.
Low platelets in the third trimester in a well woman with normal blood pressure. Which diagnosis is likely and what confirms it?
Gestational thrombocytopenia; it is mild, has no other findings and is confirmed when the count returns to normal after delivery.
Why is anti-D given to an RhD-negative woman after the birth of an RhD-positive baby?
It clears fetal RhD-positive cells from her blood before her immune system makes its own anti-D, protecting future RhD-positive babies from HDFN.
Why is low molecular weight heparin preferred to warfarin for clots in pregnancy?
Heparin does not cross the placenta, whereas warfarin does and can harm the fetus.
Elsewhere in DurgiPedia
- Maternal physiological changes in pregnancy
- Rh incompatibility
- ABO and Rh blood groups, hemolytic disease of the newborn
- Preeclampsia and eclampsia
- Newborn physiology and fetal maturation
- Newborn jaundice: visual assessment, bilirubin checks and phototherapy care
Connections
In Pharmacology2
Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.
Sources: Anaemia (World Health Organization, 2026); HELLP syndrome (MedlinePlus (U.S. National Library of Medicine), 2024); Rh incompatibility: MedlinePlus Medical Encyclopedia (MedlinePlus, U.S. National Library of Medicine, 2025); Anticoagulant Therapy In Pregnancy (StatPearls (NCBI Bookshelf), 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
